Skip to search formSkip to main contentSkip to account menu
  • Publications
  • Influence
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
View on PubMed
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
TLDR
Hyperphosphatemia and hyperparathyroidism were significantly associated with all-cause, cardiovascular, and fracture-related hospitalization, and the population attributable risk percentage for disorders of mineral metabolism was 17.5%, owing largely to the high prevalence of hyperph phosphatemia.
View on PubMed
Acute kidney injury, mortality, length of stay, and costs in hospitalized patients.
TLDR
Modest changes in SCr were significantly associated with mortality, LOS, and costs, even after adjustment for age, gender, admission International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis, severity of illness (diagnosis-related group weight), and chronic kidney disease.
View on PubMed
Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults.
TLDR
The metabolic syndrome is independently associated with an increased risk for incident CKD in nondiabetic adults and this study found that those with one, two, three, four, or five traits of the metabolic syndrome had a higher risk of developing CKD than others.
View on PubMed
Dapagliflozin in Patients with Chronic Kidney Disease.
TLDR
Among patients with chronic kidney disease, regardless of the presence or absence of diabetes, the risk of a composite of a sustained decline in the estimated GFR of at least 50%, end-stage kidney disease or death from renal or cardiovascular causes was significantly lower with dapagliflozin than with placebo.
View on PubMed
Independent association between acute renal failure and mortality following cardiac surgery.
View on PubMed
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.
TLDR
Among ambulatory adults aged 75 years or older, treating to an SBP target of less than 120 mm Hg compared with an SBp target of more than 140mm Hg resulted in significantly lower rates of fatal and nonfatal major cardiovascular events and death from any cause.
View on PubMed
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.
TLDR
Compared with calcium-based phosphate binders, sevelamer is less likely to cause hypercalcemia, low levels of PTH, and progressive coronary and aortic calcification in hemodialysis patients.
View on PubMed
Spectrum of acute renal failure in the intensive care unit: the PICARD experience.
TLDR
There is a changing spectrum of ARF in the critically ill, characterized by a large burden of comorbid disease and extensive extrarenal complications, obligating the need for dialysis in the majority of patients.
View on PubMed
Projected effect of dietary salt reductions on future cardiovascular disease.
TLDR
Moderate reductions in dietary salt could substantially reduce cardiovascular events and medical costs and should be a public health target.
View on PubMed
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License